Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species
Pharmaceutics · 21.10.2024 · 16 (10) · 1345
DOI: 10.3390/pharmaceutics16101345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 21.10.2024. Verfasst von Yuri V Khramtsov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology of Russian Academy of Sciences, 34/5 Vavilov St., 119334 Mosco…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Background/Objectives: The study of oxidative stress in cells and ways to prevent it attract increasing attention. Antioxidant defense of cells can be activated by releasing the transcription factor Nrf2 from a complex with Keap1, its inhibitor protein. The aim of the work was to study the effect of the modular nanotransporter (MNT) carrying an R1 anti-Keap1 monobody (MNTR1) on cell homeostasis.
Methods
The murine hepatocyte AML12 cells were used for the study. The interaction of fluorescently labeled MNTR1 with Keap1 fused to hrGFP was studied using the Fluorescence-Lifetime Imaging Microscopy–Förster Resonance Energy Transfer (FLIM-FRET) technique on living AML12 cells transfected with the Keap1-hrGFP gene. The release of Nrf2 from the complex with Keap1 and its levels in the cytoplasm and nuclei of the AML12 cells were examined using a cellular thermal shift assay (CETSA) and confocal laser scanning microscopy, respectively. The effect of MNT on the formation of reactive oxygen species was studied by flow cytometry using 6-carboxy-2′,7′-dichlorodihydrofluorescein diacetate.
Results
MNTR1 is able to interact with Keap1 in the cytoplasm, leading to the release of Nrf2 from the complex with Keap1 and a rapid rise in Nrf2 levels both in the cytoplasm and nuclei, ultimately causing protection of cells from the action of hydrogen peroxide. The possibility of cleavage of the monobody in endosomes leads to an increase in the observed effects.
Conclusions
These findings open up a new approach to specifically modulating the interaction of intracellular proteins, as demonstrated by the example of the Keap1-Nrf2 system.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology of Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia.
- Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory St., 119234 Moscow, Russia.
ORCID-Profile: Alexey V Ulasov, Andrey A Rosenkranz
Förderung
- Russian Science Foundation
Zitieren
APA
Khramtsov, Y. V., Ulasov, A. V., Rosenkranz, A. A., Slastnikova, T. A., Lupanova, T. N., Georgiev, G. P., & Sobolev, A. S. (2024). Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species. Pharmaceutics, 16(10), 1345. https://doi.org/10.3390/pharmaceutics16101345
Vancouver
Khramtsov YV, Ulasov AV, Rosenkranz AA, Slastnikova TA, Lupanova TN, Georgiev GP, et al. Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species. Pharmaceutics. 2024;16(10):1345. doi:10.3390/pharmaceutics16101345
BibTeX
@article{Khramtsov2024,
author = {Khramtsov, Yuri V and Ulasov, Alexey V and Rosenkranz, Andrey A and Slastnikova, Tatiana A and Lupanova, Tatiana N and Georgiev, Georgii P and Sobolev, Alexander S},
title = {Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {10},
pages = {1345},
doi = {10.3390/pharmaceutics16101345}
}
EUVIMED